Corcept Therapeutics (CORT) Free Cash Flow (QoQ) (2010 - 2026)
Corcept Therapeutics (CORT) Free Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Corcept Therapeutics |
7.66 Bn |
7.33 Bn |
162.02 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-144.20% |
| Dec 31, 2025 |
-29.52% |
| Sep 30, 2025 |
23.15% |
| Jun 30, 2025 |
848.14% |
| Mar 31, 2025 |
-92.22% |
| Dec 31, 2024 |
-16.36% |
| Sep 30, 2024 |
75.75% |
| Jun 30, 2024 |
71.63% |
| Mar 31, 2024 |
329.66% |
| Dec 31, 2023 |
-89.54% |
| Sep 30, 2023 |
25.34% |
| Jun 30, 2023 |
62.51% |
| Mar 31, 2023 |
-22.18% |
| Dec 31, 2022 |
0.18% |
| Sep 30, 2022 |
84.77% |
| Jun 30, 2022 |
-48.85% |
| Mar 31, 2022 |
-28.62% |
| Dec 31, 2021 |
1.68% |
| Sep 30, 2021 |
9.78% |
| Jun 30, 2021 |
74.81% |
